Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rexer

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Aktuelle Urologie|April 15, 2016
[Not Available]H Rexer
Aktuelle Urologie|August 1, 2015
[In Process Citation]H Rexer
Der Urologe. Ausg. A|July 15, 2015
[Deescalation chemoradiotherapy in patients with stage II A/B seminoma - study AP 13/12 of AUO]H Rexer
Der Urologe. Ausg. A|June 9, 2016
[Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO]H Rexer,
Der Urologe. Ausg. A|October 16, 2004
[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO]H Rexer
Aktuelle Urologie|June 17, 2015
[In Process Citation]H Rexer
Der Urologe. Ausg. A|June 3, 2006
[Start of a new Working Group on Urological Oncology (AUO) study of prostate cancer]H Rexer
Der Urologe. Ausg. A|March 27, 2004
[Active studies on bladder carcinoma in the year 2004]H Rexer
Der Urologe. Ausg. A|July 23, 2011
[First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO]H Rexer
Der Urologe. Ausg. A|April 15, 2014
[First-line therapy of advanced or metastasized renal cell carcinoma: phase III, open, randomized sequence study to examine efficacy and tolerance of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the first-line treatment of patients with advanced or metastasized renal cell carcinoma (SWITCH-2 - AN 33/11)]H Rexer,
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Aktuelle Urologie|April 15, 2016
[Not Available]H Rexer
Aktuelle Urologie|August 1, 2015
[In Process Citation]H Rexer
Der Urologe. Ausg. A|July 15, 2015
[Deescalation chemoradiotherapy in patients with stage II A/B seminoma - study AP 13/12 of AUO]H Rexer
Der Urologe. Ausg. A|June 9, 2016
[Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO]H Rexer,
Der Urologe. Ausg. A|October 16, 2004
[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO]H Rexer
Aktuelle Urologie|June 17, 2015
[In Process Citation]H Rexer
Der Urologe. Ausg. A|June 3, 2006
[Start of a new Working Group on Urological Oncology (AUO) study of prostate cancer]H Rexer
Der Urologe. Ausg. A|March 27, 2004
[Active studies on bladder carcinoma in the year 2004]H Rexer
Der Urologe. Ausg. A|July 23, 2011
[First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO]H Rexer
Der Urologe. Ausg. A|April 15, 2014
[First-line therapy of advanced or metastasized renal cell carcinoma: phase III, open, randomized sequence study to examine efficacy and tolerance of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the first-line treatment of patients with advanced or metastasized renal cell carcinoma (SWITCH-2 - AN 33/11)]H Rexer,
Pageof 11